APP and Alzheimer disease: The loss of GLT1 in APPswe/PS1ΔE9 mice accelerated the development of cognitive deficits and restored EAAT2 function could improve synaptic impairments, Abeta deposition, and cognitive deficiency in AD animal models [10–12].